CNTF-AX15 (Regeneron)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCNTF-AX15 (Regeneron)
Drug Alias NameAxokine (Regeneron)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCiliary neurotrophic factor receptor antagonists
TargetsCiliary neurotrophic factor receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRegeneron Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRegeneron Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A